Results 181 to 190 of about 51,607 (296)

Comparative Clinical and Imaging‐Based Evaluation of Therapeutic Modalities in CNS Embryonal Tumours With PLAGL Amplification

Neuropathology and Applied Neurobiology, Volume 51, Issue 2, April 2025.
ABSTRACT Aims Embryonal tumours with PLAGL1 or PLAGL2 amplification (ET, PLAGL) show substantial heterogeneity regarding their clinical characteristics and have been treated inconsistently, resulting in diverse outcomes. In this study, we aimed to evaluate the clinical behaviour of ET, PLAGL and elucidate their response pattern across the different ...
Michaela‐Kristina Keck, Anna Tietze, Brigitte Bison, Shivaram Avula, Julien Engelhardt, Cécile Faure‐Conter, Tanguy Fenouil, Dominique Figarella‐Branger, Einar Goebell, Johannes Gojo, Christine Haberler, Juhana Hakumäki, James T. Hayden, Laura S. Korhonen, Ewa Koscielniak, Christof M. Kramm, Mariëtte E. G. Kranendonk, Maarten Lequin, Louise E. Ludlow, David Meyronet, Per Nyman, Ingrid Øra, Thomas Perwein, Jouni Pesola, Tuomas Rauramaa, Roel Reddingius, David Samuel, Antoinette Y. N. Schouten‐van Meeteren, Alexandra Sexton‐Oates, Alexandre Vasiljevic, Thekla von Kalle, Annika K. Wefers, Pieter Wesseling, Josef Zamecnik, Michal Zapotocky, Katja von Hoff, David T. W. Jones   +36 more
wiley   +1 more source

Cytarabine-Induced Hyperbilirubinemia in a Pregnant Patient With Acute Myeloid Leukemia. [PDF]

ACG Case Rep J
Rajan A, Ahmed A, Dehghan Y, Hsieh JC, Moore C.   +4 more
europepmc   +1 more source

The Anticancer Drug Cytarabine Does not Interact with the Human Erythrocyte Membrane [PDF]

, 2003
Mario Suwalsky, Pedro Hernández, Fernando Pardo‐Manuel de Villena, Carlos P. Sotomayor   +3 more
openalex   +1 more source

Cytarabine-induced corneal toxicity [PDF]

, 2003
J Lochhead, John F. Salmon, A J Bron
openalex   +1 more source

Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia. [PDF]

Cancer Med
Liu Q, Zhang X, Lv L, Xu L, Jing Y, Gao W, Wang L, Dou L.   +7 more
europepmc   +1 more source

Improvement in cutaneous disease with menin inhibitor monotherapy in KMT2A rearranged AML

British Journal of Haematology, Volume 206, Issue 4, Page 1031-1032, April 2025.
John Chadwick, Karen Rees‐Unwin, Valarmathi Anandhan, Emma Searle   +3 more
wiley   +1 more source

MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK/STAT pathway. [PDF]

Exp Hematol Oncol
Wu J, Li X, Liu Y, Chen G, Li R, Jiang H, Yin W, Tong X, Cao R, Wang X, Liu X, Zhou F.   +11 more
europepmc   +1 more source

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti‐B4‐blocked ricin or high‐dose cytarabine [PDF]

, 2003
Ted P. Szatrowski, Richard K. Dodge, Carol Reynolds, Carol A. Westbrook, Stanley R. Frankel, Jeffrey Sklar, Carleton C. Stewart, David D. Hurd, Jonathan E. Kolitz, E Vélez-García, Richard M. Stone, Clara D. Bloomfield, Charles A. Schiffer, Richard A. Larson   +13 more
openalex   +1 more source

Cytarabine and Cardiac Failure [PDF]

American Journal of Hematology, 1992
openaire   +2 more sources

Case report: Dysphonia associated with high-dose cytarabine therapy. [PDF]

Front Pharmacol
Ma L, Huang N, Zhang H, Liu J, Zhang Z.
europepmc   +1 more source